Roe v. Miles Laboratories, Inc.

ORDER

HOLLAND, Chief Judge.

(Dismissal Granted)

Under the trade name “Koate”, defendant Miles Laboratories marketed the clotting component of human blood. Through a process called “fractionation”, “Factor VIII” (the clotting substance) is extracted from donated human blood of various individuals. It is now known that the process by which Koate was manufactured did not eradicate or exclude from this product the virus or viruses which can give rise to Acquired Immune Deficiency Syndrome (AIDS). At times here relevant, plaintiff (a hemophiliac) used Koate to control hemorrhaging. He is presumably…